DK241684D0 - Fremgangsmaade til fremstilling af et antithrombin iii-heparin-eller antithrombin iii-heparinoidkoncentrat - Google Patents

Fremgangsmaade til fremstilling af et antithrombin iii-heparin-eller antithrombin iii-heparinoidkoncentrat

Info

Publication number
DK241684D0
DK241684D0 DK2416/84A DK241684A DK241684D0 DK 241684 D0 DK241684 D0 DK 241684D0 DK 2416/84 A DK2416/84 A DK 2416/84A DK 241684 A DK241684 A DK 241684A DK 241684 D0 DK241684 D0 DK 241684D0
Authority
DK
Denmark
Prior art keywords
antithrombin iii
heparinoid
heparin
concentrate
preparing
Prior art date
Application number
DK2416/84A
Other languages
English (en)
Other versions
DK241684A (da
DK167271B1 (da
Inventor
Johann Eibl
Ernst Hetzl
Yendra Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of DK241684D0 publication Critical patent/DK241684D0/da
Publication of DK241684A publication Critical patent/DK241684A/da
Application granted granted Critical
Publication of DK167271B1 publication Critical patent/DK167271B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
DK241684A 1983-05-20 1984-05-16 Fremgangsmaade til fremstilling af et antithrombin iii- eller antithrombin iii-haperinoid-koncentrat DK167271B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT185983 1983-05-20
AT0185983A AT379310B (de) 1983-05-20 1983-05-20 Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates

Publications (3)

Publication Number Publication Date
DK241684D0 true DK241684D0 (da) 1984-05-16
DK241684A DK241684A (da) 1984-11-21
DK167271B1 DK167271B1 (da) 1993-10-04

Family

ID=3522546

Family Applications (2)

Application Number Title Priority Date Filing Date
DK241684A DK167271B1 (da) 1983-05-20 1984-05-16 Fremgangsmaade til fremstilling af et antithrombin iii- eller antithrombin iii-haperinoid-koncentrat
DK292090A DK168062B1 (da) 1983-05-20 1990-12-07 Fremgangsmaade til fremstilling af et antithrombin iii-koncentrat

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK292090A DK168062B1 (da) 1983-05-20 1990-12-07 Fremgangsmaade til fremstilling af et antithrombin iii-koncentrat

Country Status (8)

Country Link
US (1) US4510084A (da)
EP (2) EP0307002B1 (da)
JP (2) JPS59222421A (da)
AT (3) AT379310B (da)
CA (1) CA1211371A (da)
DE (2) DE3485288D1 (da)
DK (2) DK167271B1 (da)
ES (1) ES8602414A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58180162A (ja) * 1982-04-19 1983-10-21 株式会社高研 抗血栓性医用材料
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
CA1341379C (en) * 1988-04-28 2002-07-23 Welfide Corporation Purified antithrombin-iii and methods of producing the same
JP2678249B2 (ja) * 1988-06-22 1997-11-17 株式会社ミドリ十字 アンチトロンビン−▲ｉｉｉ▼製剤
JP3711561B2 (ja) * 1993-04-05 2005-11-02 三菱ウェルファーマ株式会社 アンチトロンビン−▲ｉｉｉ▼液状製剤およびその安定化方法
JPH08199580A (ja) * 1995-01-24 1996-08-06 Tetra:Kk 斜面昇降装置
US6562781B1 (en) 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
AT405739B (de) 1997-09-19 1999-11-25 Immuno Ag Verfahren zur reinigung von antithrombin iii
US5985582A (en) * 1997-12-09 1999-11-16 Sigma-Aldrich Co. Thrombin-based assay for antithrombin III
US20140206844A1 (en) 2013-01-18 2014-07-24 Prothera Biologics Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3099600A (en) * 1961-01-26 1963-07-30 Ormonoterapia Richter Spa Chromatographic purification of heparin
SE392038B (sv) * 1971-09-08 1977-03-14 Kabi Ab Forfarande for isolering av antitrombin ur blod eller blodprodukter
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4119774A (en) * 1976-03-05 1978-10-10 Ab Kabi Heparin purification method
US4087415A (en) * 1976-06-09 1978-05-02 William L. Wilson Antithrombin III
US4175182A (en) * 1978-07-03 1979-11-20 Research Corporation Separation of high-activity heparin by affinity chromatography on supported protamine
JPS6011922B2 (ja) * 1978-09-22 1985-03-29 天野製薬株式会社 高活性ヘパリンの製造法
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
GB2061687B (en) * 1979-11-02 1983-04-13 Kidd A W Grass cutting machines and improved blade therefor
DD148297A1 (de) * 1979-12-21 1981-05-20 Bezirks Inst Fuer Blutspende U Verfahren zur herstellung von prothrombinkomplexkonzentraten mit verminderter thrombogenizitaet
DE3036481A1 (de) * 1980-09-27 1982-05-19 EC Erdölchemie GmbH, 5000 Köln Verfahren zur gemeinsamen herstellung von c 4 -oligomeren und alkyl-tert.-butylethern
US4446126A (en) * 1980-09-30 1984-05-01 Cutter Laboratories, Inc. Antithrombin-heparin complex and method for its production

Also Published As

Publication number Publication date
DK168062B1 (da) 1994-01-31
JPH05320198A (ja) 1993-12-03
JPH053480B2 (da) 1993-01-14
DK241684A (da) 1984-11-21
DK167271B1 (da) 1993-10-04
EP0129534B1 (de) 1989-08-23
CA1211371A (en) 1986-09-16
ATE45747T1 (de) 1989-09-15
ATE69552T1 (de) 1991-12-15
DE3479503D1 (en) 1989-09-28
EP0129534A3 (en) 1985-12-04
DK292090D0 (da) 1990-12-07
ES532641A0 (es) 1985-12-01
ATA185983A (de) 1985-05-15
AT379310B (de) 1985-12-27
DK292090A (da) 1990-12-07
US4510084A (en) 1985-04-09
JPH07116235B2 (ja) 1995-12-13
ES8602414A1 (es) 1985-12-01
EP0307002B1 (de) 1991-11-21
EP0307002A1 (de) 1989-03-15
DE3485288D1 (de) 1992-01-02
JPS59222421A (ja) 1984-12-14
EP0129534A2 (de) 1984-12-27

Similar Documents

Publication Publication Date Title
DK292090D0 (da) Fremgangsmaade til fremstilling af et antithrombin iii-koncentrat
CA1208130A (en) ULTRAPURIFICATION OF FACTOR VIII
EP0244834A3 (en) Process for producing a factor v concentrate
DK235584D0 (da) Fremgangsmaade til fremstilling af et valleprodukt
EP0053338A3 (en) Process for the preparation of blood coagulation factors, and preparation containing factors ix and x
AU591397B2 (en) Method of preparing alpha-1-proteinase inhibitor
AU587365B2 (en) Pasteurized human fibrinogen (HF), a process for its preparation and its use
ES8100763A1 (es) Procedimiento para la preparacion de concentrado de complejoprotrombinico
ES8203609A1 (es) Procedimiento de obtencion de preparados promotores de la coagulacion sanguinea
DK241584A (da) Fremgangsmaade til fremstilling af et faktor viii (ahf)-holdigt praeparat
FI843909A0 (fi) Foerfarande foer pastoerisering av plasma eller av koncentrat av blodkoaguleringsfaktorerna ii, vii, ix och x.
AU561222B2 (en) Process for the pasteurization of human plasma
DK155499C (da) Fremgangsmaade til fremstilling af blodplasma-fraktioner
SE7714647L (sv) Immunglobulin med reducerad komplementbindning, forfarande for dess framstellning samt medel innehallande sadant immunglobulin
RO91666A (ro) Procedeu pentru prepararea unor derivati de acid fenoxiprostatrienoic
DE3165050D1 (en) Salt of furosemide or piretanide as acid component and penbutolol as base component and pharmaceutical composition containing both of the said components
ES524890A0 (es) Metodo de produccion de composiciones que contienen globulina gamma
ES8503950A1 (es) Un metodo de produccion de una preparacion de plasma activada con zymosan
IL72798A0 (en) Process for the preparation of an aqueous solution of sodium chloride
YU116989A (en) Pseudo primycine complexes, components and their additional salts with acids as well as process for making thereof
DK265084D0 (da) Fremgangsmaade til fremstilling af praeparater af human blodplasma
ES8303048A1 (es) Procedimiento de fabricacion de pienso para ganaderia.
RO89679A2 (ro) Procedeu pentru prepararea unor derivati ai 1-fenil-3-alchilsuccinimido-anilino-5-pirazolonei
IE821581L (en) Benzopyrazole derivative in cancer treatment

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
B1 Patent granted (law 1993)
PBP Patent lapsed